James Archie Harrell Jr - Chief Commercial Officer at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
AVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Archie Harrell Jr since 12/22/2023

Holdings reported by James Archie Harrell Jr for Avalo Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 36.8K $19.1K $0.52 Dec 10, 2021 Direct

Transactions reported by James Archie Harrell Jr for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.